Xiajing Chu

Ms. Xiajing Chu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TATaslim Aboudou
Taslim Aboudou
MLMeixuan Li
Meixuan Li
ZZZeliang Zhang
Zeliang Zhang
ZWzhengfeng wang
zhengfeng wang
YLYanfei Li
Yanfei Li
KYKehu Yang
Kehu Yang
This study aimed to assess the surgical outcomes of robotic compared to laparoscopic hepatectomy, with a special focus on the meta-analysis method. Original studies were collected from three Chinese databases, PubMed, EMBASE, and Cochrane Library databases. Our systematic review was conducted on 682 patients with robotic liver resection, and 1101 patients were operated by laparoscopic platform. Robotic surgery has a long surgical duration (MD = 43.99, 95% CI: 23.45–64.53, p = 0.0001), while there is no significant difference in length of hospital stay (MD = 0.10, 95% CI: −0.38–0.58, p = 0.69), blood loss (MD = −20, 95% CI: −64.90–23.34, p = 0.36), the incidence of conversion (OR = 0.84, 95% CI: 0.41–1.69, p = 0.62), and tumor size (MD = 0.30, 95% CI: −0–0.60, p = 0.05); the subgroup analysis of major and minor hepatectomy on operation time is (MD = −7.08, 95% CI: −15.22–0.07, p = 0.09) and (MD = 39.87, 95% CI: −1.70–81.44, p = 0.06), respectively. However, despite the deficiencies of robotic hepatectomy in terms of extended operation time compared to laparoscopic hepatectomy, robotic hepatectomy is still effective and equivalent to laparoscopic hepatectomy in outcomes. Scientific evaluation and research on one portion of the liver may produce more efficacity and more precise results. Therefore, more clinical trials are needed to evaluate the clinical outcomes of robotic compared to laparoscopic hepatectomy.

7 June 2023 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
JLJoao Pedro Lima
Joao Pedro Lima
XCXiajing Chu
Xiajing Chu
Gordon H. GuyattGordon H. Guyatt
Gordon H. Guyatt
WTWimonchat Tangamornsuksan
Wimonchat Tangamornsuksan
Optimal clinical decision-making requires understanding of evidence regarding benefits, harms, and burdens of alternative management options. Rigorously conducted systematic reviews and meta-analyses offer accurate summaries of the evidence. However, such summaries may review only low-certainty evidence, in the process highlighting that no single decision is likely to be best for all patients. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach offers a systematic and transparent method for rating certainty of evidence in systematic reviews. In this paper, we will address the importance of assessing the certainty associated with bodies of evidence; explain how the GRADE system rates the certainty of evidence from systematic reviews; and present the GRADE evidence to decision framework for moving from evidence to strong or weak recommendations in clinical practice guidelines.

23 May 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
XCXiajing Chu
Xiajing Chu
DCDerek K Chu
Derek K Chu
JRJunjie Ren
Junjie Ren
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
KYKehu Yang
Kehu Yang
TLThabane Lehana
Thabane Lehana
Objectives To evaluate the completeness of reporting of simulation studies on responder analysis methods and simulation performance. Design Systematic methodological survey. Data sources We searched Embase, MEDLINE (via Ovid), PubMed and Web of Science Core Collection from inception to 9 October 2023. Eligibility criteria We included simulation studies comparing responder analysis methods and assessing simulation performance (bias, accuracy, precision or variance, power, type I and II errors and coverage). Data extraction and synthesis Two independent reviewers extracted data and assessed simulation performance. We used descriptive analyses to summarise reporting quality and simulation performance. Results We identified seven simulation studies exploring augmented binary methods, distributional methods and model-based methods. No studies reported the starting seed, occurrence of failures during simulations, the random number generator used and the number of simulations. No studies reported simulation accuracy. Responder analysis results were not significantly influenced by covariate adjustment. Distributional methods remained adaptable even with skewed data. Compared with standard binary methods, augmented binary methods generated increased power and precision. When the threshold is in the tail of the distribution, a simple asymptotic Bayesian (SAB) distributional approach may not reduce uncertainty but can improve precision. Conclusion Simulation studies comparing responder analysis methods exhibit suboptimal reporting quality. Compared with standard binary methods, augmented binary methods, distributional methods and model-based methods may be better choices, but there is no best one.

16 December 2025 in PLOS ONE
Verified
Journal Article
Open access
XCXiajing Chu
Xiajing Chu
JLJoão Pedro Lima
João Pedro Lima
DZDena Zeraatkar
Dena Zeraatkar
JMJinhui Ma
Jinhui Ma
FPFemin Prasad
Femin Prasad
VCVarun Chaudhary
Varun Chaudhary
Background: Epiretinal membrane is a common retinal condition, particularly in the elderly, than can lead to reduced visual acuity and visual distortion. Structural optical coherence tomography biomarkers have shown potential for predicting visual outcomes following surgery. Objective: To evaluate the prognostic value of baseline structural optical coherence tomography biomarkers for visual outcomes following epiretinal membrane surgery. We will assess associations between individual biomarkers and postoperative visual acuity or changes in visual acuity at 6, 12, and 24 months after surgery. Methods: We will systematically search MEDLINE, EMBASE, CENTRAL and Web of Science from inception. Eligible studies will include randomized trials and observational studies reporting the association between any baseline optical coherence tomography biomarkers and postoperative visual acuity in patients undergoing epiretinal membrane surgery. Two reviewers will independently and in duplicate perform screening, data extraction, and risk of bias assessment. Meta-analyses using the restricted maximum likelihood random-effects model will be conducted whenever possible. The certainty of evidence for each estimate will be assessed using the GRADE approach. Expected outcomes: This review will analyze time-specific association between baseline structural optical coherence tomography biomarkers and postoperative visual acuity and change in visual acuity from baseline at 6, 12, and 24 months after surgery, quality of life measured using any validated scale, and adverse events.